Winton Group LTD Immuno Gen, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.55 - $6.31 $32,054 - $44,453	7,045 Added 22.81%	37,927 $188,000
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $14,112 - $20,380	3,150 Added 11.36%	30,882 $148,000
Q2 2022 Aug 10, 2022	SELL	$3.15 - $5.76 $171,589 - $313,764	-54,473 Reduced 66.26%	27,732 $125,000
Q1 2022 May 11, 2022	BUY	$4.26 - $7.48 $350,193 - $614,893	82,205 New	82,205 $391,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.